Literature DB >> 12589957

Pro-inflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2.

Nathalie Vadeboncoeur1, Mariela Segura, Dina Al-Numani, Ghyslaine Vanier, Marcelo Gottschalk.   

Abstract

Streptococcus suis serotype 2 is a world-wide agent of diseases among pigs including meningitis, septicemia and arthritis. This microorganism is also recognized as an important zoonotic agent. The pathogenesis of the meningitis caused by S. suis is poorly understood. We have previously shown that S. suis is able to adhere to human brain microvascular endothelial cells (BMEC), but not to human umbilical vein endothelial cells (HUVEC). The objective of this work was to study the ability of S. suis serotype 2 to induce the release of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1); IL-6 and the chemokines IL-8 and monocyte chemotactic protein-1 (MCP-1) by human BMEC and HUVEC, using a sandwich enzyme-linked immunosorbent assay. S. suis was able to stimulate the production of IL-6, IL-8 and MCP-1 by BMEC but not HUVEC, in a time- and concentration-dependent manner. Bacterial cell wall components were largely responsible for such stimulation. The human and pig origin of strains does not seem to affect the intensity of the response; indeed, a very heterogeneous pattern of cytokine and chemokine production was observed for the different strains tested in this study. In situ production of cytokines and chemokines by BMEC may be the result of specific adhesion of S. suis to this cell type, with several consequences such as increased recruitment of leukocytes and an increase in the blood-brain barrier permeability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589957     DOI: 10.1111/j.1574-695X.2003.tb00648.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  47 in total

Review 1.  Brain meets body: the blood-brain barrier as an endocrine interface.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

2.  Role of capsule and suilysin in mucosal infection of complement-deficient mice with Streptococcus suis.

Authors:  Maren Seitz; Andreas Beineke; Alena Singpiel; Jörg Willenborg; Pavel Dutow; Ralph Goethe; Peter Valentin-Weigand; Andreas Klos; Christoph G Baums
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

Review 3.  Concepts and mechanisms: crossing host barriers.

Authors:  Kelly S Doran; Anirban Banerjee; Olivier Disson; Marc Lecuit
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

Review 4.  The blood-brain barrier: connecting the gut and the brain.

Authors:  William A Banks
Journal:  Regul Pept       Date:  2008-04-07

5.  Mitogenic effect contributes to increased virulence of Streptococcus suis sequence type 7 to cause streptococcal toxic shock-like syndrome.

Authors:  H Zheng; C Ye; M Segura; M Gottschalk; J Xu
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

6.  Central pontine myelinolysis: historical and mechanistic considerations.

Authors:  Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2010-02-25       Impact factor: 3.584

7.  Characterization of the invasion of porcine endothelial cells by Streptococcus suis serotype 2.

Authors:  Ghyslaine Vanier; Mariela Segura; Marcelo Gottschalk
Journal:  Can J Vet Res       Date:  2007-04       Impact factor: 1.310

8.  Encapsulated Streptococcus suis inhibits activation of signaling pathways involved in phagocytosis.

Authors:  Mariela Segura; Marcelo Gottschalk; Martin Olivier
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2.

Authors:  Ghyslaine Vanier; Mariela Segura; Peter Friedl; Sonia Lacouture; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  Streptococcus suis meningitis, United States.

Authors:  Gregory T Lee; Charles Y Chiu; Barbara L Haller; Patricia M Denn; Christopher S Hall; Julie L Gerberding
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.